Skip to content

Cancer Experience Registry (CER) for Cancer Patients and Caregivers

Cancer Experience Registry: An Online Survey Research Study to Understand the Experiences of Cancer Patients and Caregivers

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02333604
Acronym
CER
Enrollment
15000
Registered
2015-01-07
Start date
2013-03-01
Completion date
2035-12-01
Last updated
2026-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Caregiver, Neoplasms

Keywords

cancer, cancer survivorship, psychosocial needs, cancer experience, acute myelogenous leukemia, breast cancer, breast cancer, metastatic, chronic lymphocytic leukemia, chronic myeloid leukemia, liver cancer, lung cancer, melanoma, multiple myeloma, myelodysplastic syndrome, ovarian cancer, prostate cancer, stomach cancer, bladder cancer, colorectal cancer, patient insights

Brief summary

The Cancer Experience Registry®: An Online Survey Research Study to Understand the Experiences of Those Impacted By a Cancer Diagnosis. The Registry is a web-based platform to distribute cross-sectional and longitudinal surveys. Study surveys are designed based on input from advisor experts, including patients and caregivers, and focus on the social, emotional, physical, financial and decision-making experiences of those who have been diagnosed with cancer and their caregivers. Findings contribute toward enhancing care for patients, survivors and caregivers via programming and policy initiatives.

Detailed description

The aims of the Registry are to: 1) better understand the psychosocial experiences and needs of people who have been impacted by cancer, including patients, survivors and caregivers; 2) inform the research community, healthcare providers, patient advocates and policy makers around gaps in care and the psychosocial challenges of people affected by cancer; 3) use the findings to develop and disseminate tailored (data-guided) programs and services that will address the emotional and social needs and ultimately improve the long-term quality of life of people affected by cancer; 4) link registrants to cancer related resources and programs via an online, modifiable platform; and 5) provide collaborating sites (e.g., hospitals/health networks/CSC affiliates) with aggregated reports on quality and needs of members or customers to enhance or improve quality of care. Findings from the Registry are disseminated online at https://www.cancersupportcommunity.org/sites/default/files/file/2020-07/CSC\_Registry\_Report\_June\_2020.pdf

Interventions

None listed

Sponsors

Cancer Support Community, Research and Training Institute, Philadelphia
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Have received a cancer diagnosis or have been a family caregiver or informal caregiver (i.e., a relative or friend) for someone diagnosed with cancer * Live in United States, a US territory, or Canada * Able to read and understand English

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Self-reported quality of life measures7 daysParticipant self-reported symptoms and functioning will be measured using the Patient-Reported Outcomes Measurement Information System-Preference Score (PROMIS-Pr). Five domains assess symptoms with higher scores corresponding to worse symptomology (Depression; Anxiety; Pain Interference; Fatigue; Sleep Disturbance) and three assess function with lower scores corresponding to worse functioning (Physical Function; Ability to Participate in Social Roles and Activities; Cognitive Function). Participants rate each item with reference to the past seven days; function scales have no timeframe specified. Scale scores are converted to standardized T scores (mean = 50, SD = 10); normative reference groups are the U.S. general population, except Sleep Disturbance, where comparisons are to a mix of the U.S. population and people with chronic illness.

Countries

United States

Contacts

CONTACTErica E. Fortune, PhD
efortune@cancersupportcommunity.org202.659.9709
CONTACTKara Doughtie, PhD
kdoughtie@cancersupportcommunity.org
PRINCIPAL_INVESTIGATORErica E. Fortune, PhD

Cancer Support Community

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 24, 2026